Are you looking to scale up your innovative digital health or medical technology company and gain a foothold in Asia? If so, the Canadian Trade Commissioner Service (TCS) invites you to… Read More
VANCOUVER, BC — Ondine Biomedical Inc. (LON: OBI), has recruited the final patient to its nasal photodisinfection exploratory Phase 2 trial. The trial is evaluating how effectively Ondine’s nasal photodisinfection… Read More
Approximately 6,000 participants 5 years of age and older will be enrolled in Lyme disease-endemic regions in Europe and the U.S. NEW YORK & SAINT-HERBLAIN, FRANCE– Pfizer Inc. (NYSE: PFE) and Valneva… Read More
Phase 1 Tarlatamab Study Showed Encouraging Antitumor Activity With Median Duration of Response of 13 Months in Small Cell Lung Cancer No Approved Treatment Options Available to Patients in Third-line Setting… Read More
Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with potential combined worldwide peak sales of more than $3 billion Potential to address… Read More
